Complicaciones del paciente diabético con COVID-19.

José Leonardo Cedeño Torres; Karol Cristina Muñoz López; Luis Carlos Alonzo Tumbaco; Ilya Isadora Casanova Romero

doi:10.46377/dilemas.v10i18.3416

José Leonardo Cedeño Torres Universidad Laica Eloy Alfaro de Manabí
Karol Cristina Muñoz López Universidad Laica Eloy Alfaro de Manabí
Luis Carlos Alonzo Tumbaco Universidad Laica Eloy Alfaro de Manabí
Ilya Isadora Casanova Romero Universidad Laica Eloy Alfaro de Manabí

DOI: https://doi.org/10.46377/dilemas.v10i18.3416

Palabras clave: Diabetes tipo 2, COVID-19, infección por Sars-Cov2

Resumen

Se analizan las complicaciones de los pacientes diabéticos en el Hospital General Manta en el periodo marzo 2020 - marzo 2021. Fue un estudio cuantitativo, descriptivo y retrospectivo. Los resultados indicaron que los pacientes diabéticos atendidos por COVID-19 corresponden en un 62,7% a hombres con rango de edad dominante entre los 61-70 años con un 33,5%; el 52,2% de diabéticos presentó afectación pulmonar moderada y el 33,4% grave; el Síndrome de Insuficiencia Respiratoria Aguda se presentó en un 58,2% y el 66,1% tuvo hipoxemia severa como complicación; el 32,3% de los diabéticos ingresó a la Unidad de Cuidados Intensivos (UCI), y del total que ingresaron, el 86,5% falleció. Se concluye, que la mayoría de los pacientes presentó complicaciones de moderada a severa durante la infección por Sars-CoV2 con una elevada mortalidad en UCI.

Citas

Abu-Farha, M., Al-Mulla, F., Thanaraj, T. A., Kavalakatt, S., Ali, H., Abdul Ghani, M., & Abubaker, J. (2020). Impact of diabetes in patients diagnosed with COVID-19. Frontiers in immunology, 11, 576818.

Alejandro, E. U., Mamerto, T. P., Chung, G., Villavieja, A., Gaus, N. L., Morgan, E., & Pineda-Cortel, M. R. B. (2020). Gestational diabetes mellitus: a harbinger of the vicious cycle of diabetes. International journal of molecular sciences, 21(14), 5003.

Dhama, K., Khan, S., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., ... & Rodriguez-Morales, A. J. (2020). Coronavirus disease 2019–COVID-19. Clinical microbiology reviews, 33(4), e00028-20.

Fox, C. S., Golden, S. H., Anderson, C., Bray, G. A., Burke, L. E., De Boer, I. H., ... & Vafiadis, D. K. (2015). Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation, 132(8), 691-718.

Halvatsiotis, P., Kotanidou, A., Tzannis, K., Jahaj, E., Magira, E., Theodorakopoulou, M., ... & Dimopoulos, G. (2020). Demographic and clinical features of critically ill patients with COVID-19 in Greece: The burden of diabetes and obesity. Diabetes research and clinical practice, 166, 108331.

Kazi, A. A., & Blonde, L. (2001). Classification of diabetes mellitus. Clinics in laboratory medicine, 21(1), 1-13.

Kerbl, R., & Zepp, F. (2021). Coronavirus disease 2019. Monatsschrift Kinderheilkunde, 169(4), 308-311.

Khan, R. M. M., Chua, Z. J. Y., Tan, J. C., Yang, Y., Liao, Z., & Zhao, Y. (2019). From pre-diabetes to diabetes: diagnosis, treatments and translational research. Medicina, 55(9), 546.

Moderbacher, C. R., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., ... & Crotty, S. (2020). Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell, 183(4), 996-1012.

Pasquel, F. J., & Umpierrez, G. E. (2014). Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes care, 37(11), 3124-3131.

Varghese, P. M., Tsolaki, A. G., Yasmin, H., Shastri, A., Ferluga, J., Vatish, M., ... & Kishore, U. (2020). Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies. Immunobiology, 225(6), 152008.

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., ... & Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, 323(11), 1061-1069.

World Health Organization. (2022). COVID-19 weekly epidemiological update, edition 97, 22 June 2022. https://apps.who.int/iris/handle/10665/357163

Wu, C., Chen, X., Cai, Y., Zhou, X., Xu, S., Huang, H., ... & Song, Y. (2020). Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA internal medicine, 180(7), 934-943.

Yan, Y., Yang, Y., Wang, F., Ren, H., Zhang, S., Shi, X., ... & Dong, K. (2020a). Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ open diabetes research and care, 8(1), e001343.

Yang, H., Sloan, G., Ye, Y., Wang, S., Duan, B., Tesfaye, S., & Gao, L. (2020). New perspective in diabetic neuropathy: from the periphery to the brain, a call for early detection, and precision medicine. Frontiers in endocrinology, 10, 929.

Zhang, J. Y., Shang, T., Ahn, D., Chen, K., Coté, G., Espinoza, J., Mendez, C. E., Spanakis, E. K., Thompson, B., Wallia, A., Wisk, L. E., Kerr, D., & Klonoff, D. C. (2021). How to Best Protect People with Diabetes from the Impact of SARSCoV-2: Report of the International COVID-19 and Diabetes Summit. Journal of Diabetes Science and Technology, 15(2), 478–514.

Zhang, Y., Cui, Y., Shen, M., Zhang, J., Liu, B., Dai, M., ... & Pan, P. (2020). Association of diabetes mellitus with disease severity and prognosis in COVID-19: a retrospective cohort study. Diabetes research and clinical practice, 165, 108227.

Zimmet, P. Z. (2017). Diabetes and its drivers: the largest epidemic in human history? Clinical diabetes and endocrinology, 3(1), 1-8.